Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H28N2O4 |
Molecular Weight | 348.4366 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)C1=CC2=C(N1)C=CC=C2OCC(O)CNC(C)(C)C
InChI
InChIKey=SJYFDORQYYEJLB-UHFFFAOYSA-N
InChI=1S/C19H28N2O4/c1-12(2)25-18(23)16-9-14-15(21-16)7-6-8-17(14)24-11-13(22)10-20-19(3,4)5/h6-9,12-13,20-22H,10-11H2,1-5H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1348421
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1348421
Caprindolol, also known as SDZ 21009, is a beta-adrenoceptor blocker with affinity for serotonin (5-HT1A and 5-HT1B receptors.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094118 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1348421 |
|||
Target ID: CHEMBL1898 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7972302 |
|||
Target ID: CHEMBL214 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1681448 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. | 1989 Jul |
|
Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptors. | 1994 Aug |
|
Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin. | 1994 Jan |
|
5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro. | 2002 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1348421
anticonflict effect of m-CPP in rats: The anticonflict effect of m-CPP (0.25 mg/kg) was antagonized by the beta-adrenoceptor blocker SDZ 21009 (2 and 4 mg/kg) with affinity for 5-HT1A and 5-HT1B receptors
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11861321
The inhibitory effects of serotonin (5-HT), α-methylserotonin (α-met-5-HT) and 5-carboxamidotryptamine (5-CT) were attenuated by the non-specific 5-HT antagonist methiothepin (1 μM) and by the 5-HT1A/1B antagonist SDZ 21009 (100 nM) but not by the selective 5-HT1A antagonist WAY 100135 (1 μM).
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4678
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
W8F97XP38W
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
100000081345
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
C76020
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
Carpindolol
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
DTXSID3049041
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
CHEMBL1742440
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
SUB06141MIG
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
193949
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY | |||
|
39731-05-0
Created by
admin on Fri Dec 15 16:24:03 GMT 2023 , Edited by admin on Fri Dec 15 16:24:03 GMT 2023
|
PRIMARY |
ACTIVE MOIETY